Web Exclusives

Thumbnail image for Embedding ethics in pharma’s DNA

Embedding ethics in pharma’s DNA

Compliance training should focus on promoting trust and integrity, rather than on fear of the consequences of non-compliance. Louise Vamvoukaki offers an insight into how AstraZeneca is working to ensure that its globally dispersed workforce are all living and breathing the same values and ethics.

25th April 2019

Thumbnail image for Nothing less than a bleed-free life

Nothing less than a bleed-free life

To mark World Haemophilia Day, Laurence Woollard talks to PharmaTimes about engaging today’s generation of young people living with the condition to advocate for nothing less than a bleed-free life

17th April 2019

Thumbnail image for Lonely at the top?

Lonely at the top?

Ex England cricketer Jeremy Snape says pharma leaders looking to inspire their teams during volatile times should see what lessons they can learn from other industries faced with similar challenges

15th April 2019

Thumbnail image for AI and pharma sales

AI and pharma sales

Alex Dale looks at where we are with AI and how it might help pharma sales

28th March 2019

Thumbnail image for The Amazon effect

The Amazon effect

The pharma industry needs to transform the supply chain from a source of regulatory risk to a legitimate business opportunity.

11th March 2019

Thumbnail image for The rise of virtual pharma

The rise of virtual pharma

The rise of virtual business models in biopharma reflects the changing face of the pharmaceutical industry - big pharma discovering and developing its own pipeline exclusively in-house no longer exists.

11th February 2019

Thumbnail image for Medical devices regulation countdown

Medical devices regulation countdown

Cliodhna McDonough says new regulations on the horizon for medical devices in Europe present a huge challenge to manufacturers, but could also deliver improved confidence in the consistency and effectiveness of the regulatory process.

11th February 2019

Thumbnail image for The SPC eligibility issue

The SPC eligibility issue

The European Court should prepare for legal challenges to the ineligibility of new medical technologies for Supplementary Protection Certificates (SPCs).

23rd January 2019

Thumbnail image for Redefining Value

Redefining Value

In today’s highly competitive healthcare market how can pharma companies stand out from the crowd? Showing brand value has never been more important.

23rd January 2019

Thumbnail image for The controversy over gene-editing

The controversy over gene-editing

CRISPR has the potential to transform a variety of scientific areas, but this genome editing technique is also shrouded in controversy, particularly regarding its potential use to create genetically engineered humans.

10th January 2019

Previous  --   1 2 3 4 5 6   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download